Nivalis Therapeutics Fund Predictions

NASDAQ Stock Exchange

Open Broker Account

$2.40

+0 (+0%)

At Close: Aug 09, 2017

Currently predicting for Mon, 6 May 2024

Trading levels for NVLS

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	2.50	4.17 %
		R2	2.46	2.42 %
		R1	2.43	1.33 %
Current price:			2.40
	Support	S1	2.35	-2.17 %
		S2	2.32	-3.25 %
		S3	2.28	-5.00 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	2.45	2.08 %
		R2	2.42	0.83 %
		R1	2.41	0.417 %
Current price			2.40
	Support	S1	2.39	-0.417%
		S2	2.35	-2.08%
		S3	2.29	-4.58%

NVLS Predictions History

7 years ago
Daniel predicted that NVLS for 2017-01-17 is going $2.60 (17.12%)

Rank:

About Nivalis Therapeutics

Nivalis Therapeutics, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of product candidates for patients with cystic fibrosis (CF). CF is a life-shortening genetic disease. Its lead product candidate is N91115, a small molecule that is in Phase II clinical trial, which addresses a defect in cystic fibrosis transmembrane conductance regulator (CFTR), resulting from mutations in the CFTR g... NVLS Profile

Golden Star

Ticker	Date	Change	Price
CVBF	May 01	2.75%	$16.75
FTSL	May 01	0.282%	$46.03
EQC	Apr 30	0.694%	$18.72
HRB	Apr 30	0.635%	$47.23
BSCQ	Apr 30	0.576%	$19.09
BSJP	Apr 29	0.306%	$22.91
LYG	Apr 29	1.56%	$2.56
ORA	Apr 29	4.68%	$64.48
DHT	Apr 24	3.10%	$11.28
LPLA	Apr 19	3.12%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In